Rapid Correction of the Hypoglycemia State in Nonhuman Primates Using a Glucagon Long-Dissolving Microneedle Patch

• Published in: ACS biomaterials science & engineering Vol. 10; no. 5; pp. 3086 - 3096
• Main Authors: Yu, Xiang, Wen, Xueyu, Xu, Jianchen, Zhou, Qiao, Chen, Yingrong, Qu, Fengli, He, Min, Chang, Hao, Zheng, Chao
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 13.05.2024
• Subjects: Administration, Cutaneous; Animals; Blood Glucose - analysis; Blood Glucose - drug effects; Controlled Release and Delivery Systems; Drug Delivery Systems - instrumentation; Glucagon - administration & dosage; Glucagon - pharmacokinetics; Hypoglycemia - blood; Hypoglycemia - drug therapy; Macaca mulatta; Male; Needles; Rats; Rats, Sprague-Dawley; Transdermal Patch; microneedles; blood glucose; glucagon; transdermal delivery; hypoglycemia
• ISSN: 2373-9878; 2373-9878
• DOI: 10.1021/acsbiomaterials.3c01962

The timely administration of glucagon is a standard clinical practice for the treatment of severe hypoglycemia. However, the process involves cumbersome steps, including the reconstitution of labile glucagon and filling of the syringe, which cause considerable delays in emergency situations. Moreover, multiple dosages are often required to prevent the recurrence of the hypoglycemic episode because of the short half-life of glucagon in plasma. Herein, we develop a glucagon-loaded long-dissolving microneedle (GLMN) patch that exhibits the properties of fast onset and sustained activity for the effective treatment of severe hypoglycemia. Three types of MN patches were fabricated with different dimensions (long, medium, and short). The longer MN patch packaged a higher dosage of glucagon and exhibited supreme mechanical strength compared to the shorter one. Additionally, the longer MN patch could insert more deeply into the skin, resulting in higher permeability of glucagon across the skin tissue and more rapid systemic absorption as compared with the shorter MN patch. The GLMN patch was observed to reverse the effects of hypoglycemia within 15 min of application in animal models (specifically, rat and rhesus monkey models) and maintained long-term glycemic control, owing to highly efficient drug permeation and the drug reservoir effect of the MN base. The current study presents a promising strategy for the rapid reversal of severe hypoglycemia that exhibits the desirable properties of easy use, high efficiency, and sustained action.